Myelodysplastic Syndrome and Colon Cancer Relationship: A Case Report

Jasem Al Barrak, Asit Mohanty and Asmaa El Hussainy
Additional contact information
Asmaa El Hussainy: Department of medical oncology, KCCC, Kuwait

Cancer Therapy & Oncology International Journal, 2020, vol. 17, issue 1, 1-4

Abstract: The use of alkylating agent and antimetabolite is associated with the development of therapy related acute leukemia or myelodysplastic syndrome. MDS may also occur as a separate entity in Patients of CRC who are treated with chemotherapy. The average time until onset of tMDS depends on the type and amount of chemotherapy used and varies from 2 to 7 years. We are presenting a case that had MDS shortly after treatment of CRC with Adjuvant Chemotherapy which is not a common entity.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555951.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555951.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:17:y:2020:i:1:p:1-4

DOI: 10.19080/CTOIJ.2020.17.555951

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().